These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8759898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K, Futaki M, Dan K, Nomura T.
    Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia.
    LeBrun DP, Pinkerton PH, Sheridan BL, Chen-Lai J, Dubé ID, Poldre PA.
    Cancer Genet Cytogenet; 1991 Jul 01; 54(1):21-5. PubMed ID: 2065312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.
    Shepherd P, Suffolk R, Halsey J, Allan N.
    Br J Haematol; 1995 Mar 01; 89(3):546-54. PubMed ID: 7734353
    [Abstract] [Full Text] [Related]

  • 12. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X, Pan J, Qiu H, Cen J, Xue Y, Chen S, Shen H, Yao L, Zhang J, Wu Y, Chen Y.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar 01; 35(3):210-4. PubMed ID: 24666486
    [Abstract] [Full Text] [Related]

  • 13. BCR-ABL rearrangement frequencies in chronic myeloid leukemia and acute lymphoblastic leukemia in Ecuador, South America.
    Paz-y-Miño C, Burgos R, Morillo SA, Santos JC, Fiallo BF, Leone PE.
    Cancer Genet Cytogenet; 2002 Jan 01; 132(1):65-7. PubMed ID: 11801312
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
    Valiente A, Outeriño J, Martín Calderín F, Benítez J.
    Sangre (Barc); 1990 Dec 01; 35(6):481-3. PubMed ID: 2087668
    [Abstract] [Full Text] [Related]

  • 17. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K, Nomura T.
    Leuk Lymphoma; 1993 May 01; 10(1-2):9-15. PubMed ID: 8374529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
    Cesar JM, Cabello P, Ferro T, Navarro JL.
    Cancer Genet Cytogenet; 2006 May 01; 167(1):74-7. PubMed ID: 16682291
    [Abstract] [Full Text] [Related]

  • 20. [Chronic myelogenous leukemia expressing two bcr-abl chimeric mRNA; a case report].
    Hashimoto S, Hiyoshi M, Hino M, Yamane T, Ota T, Koh KR, Tagawa S, Tatsumi N.
    Rinsho Ketsueki; 1997 Jan 01; 38(1):72-4. PubMed ID: 9028165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.